The red biotechnology market presents opportunities in biopharmaceutical production, gene therapy, and precision medicine development. Advancements in genetic engineering and growing needs for ...

(MENAFN- GlobeNewsWire - Nasdaq) The red biotechnology market presents opportunities in biopharmaceutical production, gene therapy, and precision medicine development. Advancements in genetic ...

The red biotechnology market presents opportunities in biopharmaceutical production, gene therapy, and precision medicine development. Advancements in genetic engineering and growing needs for ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in major depressive disorder. Draig Therapeutics has emerged from a ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

Pharmaceutical industry accidents raise concerns about worker and community safety, prompting calls for stricter regulations ...

The ASX fell 0.11pc in trade, with 7 of 11 sectors lower. The resources industry was a silver lining; both gold and iron ore ...

Shares of Cogent Biosciences were trading in the red in Tuesday's after-hours market, following news the biotechnology company commenced an underwritten public offering for $150 million of its common ...

The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising ...

The red biotechnology market is expanding due to key applications, including gene therapy, molecular diagnostics, monoclonal antibodies, vaccines, pharmacogenomics, stem cells, biopharmaceuticals, and ...

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...